During placental development, mononuclear villous cytotrophoblast cells differentiate and fuse with the overlying syncytiotrophoblast. This process requires the dissolution of E-cadherin (CDH1)-containing adherens junctions in cytotrophoblast. Integrin linked kinase (ILK) can downregulate CDH1 through poly (ADP-ribose) polymerase 1 (PARP1) and Snail-1 (SNAI1) during epithelialmesenchymal transition. ILK is known to be expressed in cytotrophoblast; thus, the role of a potential ILK-PARP1-SNAI1 pathway in aiding trophoblast syncytialization via the downregulation of CDH1 was examined. The spatiotemporal expression of PARP1, SNAI1, and CDH1 were determined in first and early second trimester chorionic villi, term villi, and BeWo cells by immunofluorescence analysis. PARP1 and SNAI1 were highly detectable in villous cytotrophoblast nuclei of human chorionic villi and SNAI1 expression, in particular, also persisted in syncytiotrophoblast. In BeWo cells undergoing syncytialization, PARP1 and SNAI1 increasingly localized to cell nuclei in correlation with decreased CDH1 expression. Using luciferase reporter assays, it was determined that PARP1 and SNAI1 promoter activities were significantly higher in BeWo cells during syncytialization compared to the activities in proliferating cells. Overexpression of wild type or constitutively active ILK also resulted in significantly increased PARP1 and SNAI1 promoter activities while dominant negative ILK overexpression significantly reduced promoter activities. Lastly, siRNA-mediated depletion of ILK expression in BeWo cells undergoing syncytialization resulted in significantly reduced SNAI1 expression and a significant reduction in the incidence of syncytialization correlating with increased CDH1 expression. These results demonstrate that ILK aids trophoblast syncytialization via the downregulation of CDH1, perhaps through an ILK-PARP1-SNAI1 pathway.
Introduction
The placenta is a highly specialized transient organ formed during pregnancy that possesses an array of metabolic, hormonal, and immunological functions supporting the normal growth, development, and viability of the fetus and the health of the mother [1] [2] [3] [4] . The importance of proper placental development to the health and wellbeing of both the fetus and mother is exemplified in a wide range of pregnancy complications including pre-eclampsia, intrauterine growth restriction, and gestational diabetes, which are thought to be the result, at least in part, of placental abnormalities [5, 6] . Despite years of research and the development of new investigative tools and approaches to facilitate the study of placental development, the molecular basis of syncytiotrophoblast (STB) differentiation during placentation is still not fully understood.
Within the first few weeks of pregnancy, the chorionic villi are spatially segregated into two types: the anchoring villi and the floating villi [7] . The floating villi represent the majority of the villi and are bathed in maternal blood within an intervillous space to facilitate functions such as the exchange of gas, nutrients, and waste and to aid in the secretion of hormones. The villi consist of a bilayered epithelium throughout the majority of pregnancy with an inner proliferative population of mononuclear stem cytotrophoblast (CTB) cells and an outer nonproliferative population of multinuclear STB cells [4, 8] . Jones et al. [9] using transmission electron microscopy and immunofluorescence demonstrated that villous CTB cells transform from a cuboidal phenotype that form a complete layer in early gestation to a more flattened shape with multiple interconnecting processes at term that cover less of the basal lamina surface.
In vitro studies have indicated that syncytialization can be regulated by various cytokines, growth factors, adhesion molecules, and kinases from both maternal and fetal tissues [10] [11] [12] [13] . The mitogenactivated protein kinases 1/3 (MAPK1/3) and MAPK14 as well as the Sarcoma family (SRC) kinases have been demonstrated to be important for trophoblast differentiation and fusion [14, 15] . Syncytin (ERVW-1), a retroviral envelope protein, has a direct role in human trophoblast fusion [16] with glial cells missing homolog 1 (GCM1), a transcription factor that is upregulated in prefusing CTB, regulating ERVW-1 expression [17, 18] . Notably, the adherens junction protein E-cadherin (CDH1) is highly detectable at points of CTB cell-cell contact and its expression markedly decreases with remodeling of cell-cell adhesion complexes associated with differentiation and subsequent fusion of CTB to STB [19] . The CDH1 gene promoter contains E-box motifs, which are central to the repression of CDH1 expression [20] . Several transcriptional repressors were found to interact with E-box motifs, such as the TWIST, ZEB, and SNAI families of transcription factors [21] [22] [23] . Incidentally, TWIST was reported to regulate cadherin-mediated trophoblast fusion [24] .
Integrin linked kinase (ILK) is an intracellular serine/threonine kinase and adapter protein that localizes to focal adhesions and is critically involved in signal transduction and the adhesion of cells to their extracellular environment [25, 26] . ILK interacts with the cytoplasmic domains of beta-integrins and numerous cytoskeletalassociated proteins and has been found to mediate protein-protein interactions [27, 28] . Elustondo et al. [29] reported that ILK was highly expressed in situ in villous CTB cells and in stromal mesenchyme in first trimester and early second trimester human chorionic floating villi; however, it was scarcely detected in the STB layer. Overexpression of ILK was also demonstrated to aid syncytialization and hormonal differentiation of BeWo trophoblast cells [30] .
Hannigan et al. [31] first demonstrated that overexpression of ILK in epithelial cells results in disrupted cell-cell adhesion. ILK downregulates CDH1 expression through activation of the transcriptional repressor Snail (SNAI1), independent of CTNNB1 /T-cell factor 7 (TCF7) regulation [32] and an ILK-poly (ADP-ribose) polymerase 1 (PARP1)-SNAI1 pathway has also been proposed for modulating CDH1 expression and subsequent epithelial-mesenchymal transition (EMT) processes [33] .
Since ILK and CDH1 are expressed in the CTB of the chorionic villi during the first trimester of pregnancy, it was hypothesized that ILK may also be part of an ILK-PARP1-SNAI1 signaling pathway to regulate differentiation and fusion of CTB into the syncytiotrophoblast. Thus, the expression of PARP1 and SNAI1 in chorionic villi in situ and in syncytializing BeWo trophoblast cells was characterized. Furthermore, the necessity of ILK for syncytialization and the effect of ILK depletion on trophoblast expression of PARP1 and SNAI1 were examined.
Materials and methods

Human placental tissue collection
Ethics approval for the study (Protocol #03.44) was acquired from the Health Care Corporation of St. John's Research Proposals Approval Committee and the Human Investigation Committee of Memorial University of Newfoundland. Human placental tissue was collected from elective social terminations at weeks 8-14 of gestation, following dilatation and curettage, as well as at term (37-40 weeks) at the Health Science Centre (Memorial University of Newfoundland). Tissues were placed in phosphate-buffered saline (PBS; pH 7.40), processed, and fixed as described in [29] . Tissue processing, embedding, and sectioning were conducted by the Histology Unit of the Faculty of Medicine, Memorial University of Newfoundland. Two 5-μm-thick serial tissue sections were mounted per glass slide so one section could serve as a negative control for experiments.
BeWo cell culture
The BeWo cell line was purchased from the American Type Culture Collection (Cat. #CCL-98, Manassas, VA). This cell line was originally derived from a human trophoblast choriocarcinoma and undergoes syncytialization upon forskolin treatment [34] . BeWo cells can be grown under proliferating conditions indefinitely where they exhibit an epithelial phenotype or under syncytialization conditions where they express markers of STB such as human chorionic gonadotropin (CGB3), ERVW-1, with markedly decreased CDH1, and desmoplakin (DSP) expression and syncytialization of up to 80% [19, [35] [36] [37] [38] .
Cells were cultivated under standard condition in 75 cm 2 culture flasks in Hams F-12 media with L-glutamine (Cat. #11765-062; Life Technologies, Burlington, Ontario, Canada) supplemented with 10% fetal bovine serum (Cat. #16000-044; Life Technologies) and 100 U penicillin/100 μg streptomycin (Cat. #15140-122; Life Technologies) as has been described elsewhere [30] . This tissue culture media formulation and associated culture parameters were designated as proliferating conditions. To promote syncytialization, the same culture conditions as above were utilized except Ham's F-12K media (Cat. # 21127-022, Life Technologies) containing 50 μM forskolin (Cat. #F6886; Sigma Aldrich, Oakville, Ontario, Canada) was used. 
Immunofluorescence analysis Placental chorionic villi
Sections were deparaffinized in xylene and rehydrated in a descending series of ethanol followed by a wash in PBS. Heat-induced epitope retrieval was performed in a 10 mM sodium citrate solution (pH 6.0) [39] . Slides were then cooled for 20 min and rinsed with PBS for 10 min. Subsequently, tissue sections were incubated with 0.1% Trypsin/PBS (Cat # T7168; Sigma Aldrich) for 10 min at room temperature followed by a wash in PBS [29] . Tissue sections were blocked in 5% normal goat serum/1% horse serum/1% fetal bovine serum in PBS to prevent nonspecific antibody binding. Sections were then incubated overnight at 4
• C in appropriate primary antiserum (Table 1) or with affinity purified control IgG of the appropriate species used at the same concentration as the primary antiserum. All tissue sections were then washed twice with PBS and incubated with appropriate secondary antiserum ( in proliferating conditions for 24 h. Cells were then fixed in 4% paraformaldehyde/PBS for 5 min (0 h) or subsequently at 12, 24, or 48 h after culture in syncytialization conditions. Cells were permeabilized in PBS containing 0.1% Triton X-100 (PBT) for 15 min at room temperature followed by a wash with PBS for 5 min. BeWo cells were then blocked in 5% normal goat serum/1% horse serum/1% fetal bovine serum in PBS for 1 h, and then incubated for 1 h at room temperature in appropriate primary antiserum (Table 1) . Affinitypurified mouse and rabbit IgG, at the same concentration as the primary antiserum, served as negative controls for immunofluorescence analyses. After three washes in PBT, cells were incubated with appropriate secondary antiserum ( Table 1) . The cells were then washed two times with PBT and mounted in Vectashield containing DAPI or in co-immunofluorescence experiments, cells were blocked and incubated with additional primary and secondary antisera as above. All cells were observed using a Leica DM-IRE2 inverted microscope (Leica Microsystems) equipped for epifluorescence illumination and attached to a Retiga Exi CCD camera (QImaging, Burnaby, British Columbia, Canada). Openlab Image Analysis software (Version 5.5; Improvision, Inc., Lexington, MA) was used for image capture and analysis.
Immunoblot analysis
BeWo cells were lysed in NP-40 lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% Nonidet P-40) and collected as described previously [30] . Protein sample concentrations were determined by the Bradford assay [40] using the Bio-Rad protein assay dye reagent (Cat. # 500-0006; Bio-Rad Laboratories, Mississauga, Ontario, Canada). Samples (30 μg of total protein/lane) were then separated electrophoretically in 10% polyacrylamide gels under denaturing conditions as previously described [30] . Gels were electroblotted to Pierce 0.45 μm nitrocellulose membranes (Cat. #88018; Thermo Fisher Scientific, Mississauga, Ontario, Canada). Unless otherwise stated, all washes and antisera incubations were conducted at room temperature under constant agitation. Membranes were washed with Tris-buffered saline Tween-20 (TBST; 20 mM Tris, 137 mM NaCl, and 0.1% Tween-20, pH 7.6). The membranes were then blocked with 5% milk powder in TBST for 1 h, and appropriate antiserum (Table 1) was added to the membranes for incubation at 4
• C overnight. Immunoblots were then washed with TBST followed by incubation in relevant horseradish peroxidase (HRP)-conjugated secondary antiserum (Table 1 ) for 1 h. The immunoblots were again washed with TBST and protein-antisera complexes were detected using the Pierce SuperSignal West Pico chemiluminescent substrate detection system (Cat. # 34080; Thermo Fisher Scientific). Multiple exposures were generated on enhanced chemiluminescence optimized X-ray film to ensure the linearity of the film responses.
Luciferase reporter assays
To assess GCM1, PARP1, and SNAI1 gene promoter activities under proliferation and syncytialization conditions, BeWo cells were transfected with an Amaxa Nucleofection System using program X-005 [41] according to the manufacturer's instructions (Lonza Ltd., Allendale, NJ). For transfection, 1.8 μg of luciferase reporter expression vectors GCM1 PROM 01 (Cat. # S101612; Switchgear, Menlo Park, CA), PARP1 PROM 01 (Cat. # S119690; Switchgear), SNAI1 PROM 01 (Cat. # S122793; Switchgear), EMPTY PROM (Cat. # S190005; Switchgear), or GAPDH PROM 01 (Cat. # S121624; Switchgear) and 0.2 μg of a galactosidase beta 1 (GLB1) reporter construct (kind contribution from Dr. L. Gillespie, Memorial University of Newfoundland, Newfoundland and Labrador, Canada) were used. Following transfection, cells were transferred to six-well tissue culture plates and incubated overnight. The next day the cells were cultured in either proliferation or syncytialization conditions, with media being renewed every 24 h. After 48 h of culture the cells were lysed and assayed for luciferase activity.
To determine if ILK protein overexpression in BeWo cells could regulate GCM1, PARP1, and SNAI1 gene promoter activities, BeWo cells were transfected as described above using 1.8 μg of empty pEGFP-C3 vector (Cat. #6082-1; BD Clontech, Mountain View, CA), pEGFP-C3 containing wild-type (wt)-ILK, dominant negative E359K (dn)-ILK, or constitutively active S343D (ca)-ILK (kind contributions from Dr. G. Hannigan, Monash University, Australia) [30] along with 0.2 μg of a GLB1 construct and 0.2 μg of appropriate luciferase reporter expression vectors. Following transfection, cells were then transferred to six-well plates and cultured under syncytialization conditions. After 48 h of culture, the cells were lysed and assayed for luciferase activity.
For luciferase assays, the cell lysates were analyzed with a Promega Luciferase Assay System kit (Cat # PRE1500, Thermo Fisher Scientific) according to the manufacturer's instructions. Luciferase activities were corrected for cellular protein concentrations measured with Bradford assays and calculated as luciferase units per milligram of protein. All assays were performed in triplicate. A GLB1 assay was also performed on each sample to normalize for transfection efficiency. Thirty microliters of cell lysate were analyzed with a Promega Beta-Galactosidase Enzyme Assay System kit (Cat # PRE2000, Thermo Fisher Scientific) according to the manufacturer's instructions. targeting and the effect of ILK depletion on expression of signaling partners were determined by immunoblot analyses as described above. Cells were also grown on glass coverslips seated in 35-mm culture dishes, fixed, and prepared for immunofluorescence experiments to determine the incidence of syncytialization, upon ILK depletion, compared to control cells. Syncytialization was considered genuine when at least three or more nuclei were present in the same membrane-bound cytoplasm as previously described [30] . Membranes were detected by CDH1 immunostaining, and the incidence of syncytialization (%) was determined in 20 microscopic high power fields of view (400× observed magnification) per experiment (n = 3) by calculating the number of nuclei in syncytia/total number of nuclei multiplied by 100. A total of 1235 nuclei were counted in ILK-depleted cells and 746 nuclei in nontargeting control (NTC) cells.
Data analysis
Statistical analysis was performed with GraphPad Prism version 5.01 (GraphPad Software, San Diego, CA). Statistical significance for the determination of the incidence of BeWo cell fusion and luciferase assays was analyzed with a t-test or a one-way analysis of variance (ANOVA) and a Newman-Keuls multiple comparisons test. Values were considered significantly different if P < 0.05. Densitometric analyses of immunoblot data were conducted with Image J and analyzed with a t-test.
Results
Spatiotemporal localization of PARP1 and SNAI1
Human chorionic villi during gestation
To assess PARP1 localization in human chorionic villi, immunofluorescence experiments were conducted on normal first and second trimester, as well as term placentae. In both first and second trimester chorionic villi, PARP1 was highly expressed in the villous CTB nuclei including nucleoli (Figure 1 ). In contrast, PARP1 detection was substantially decreased in the STB, relative to CTB. In term placenta, PARP1 immunolocalization was scarce in both villous CTB and STB when compared to first and second trimester chorionic villi. PARP1 expression in CTB was confirmed by the detection of CDH1 in PARP1 expressing cells (Figure 1, merged panels) . CDH1 was highly detected in the cell membranes of CTB throughout the first and second trimesters of pregnancy. At term, CDH1 immunoreactivity was confined to the membranes of very thin CTB cells with fewer nuclei apparent in comparison to first and second trimester chorionic villi.
To examine the potential for PARP1 and SNAI1 co-expression in trophoblast nuclei, co-immunofluorescence experiments were conducted on first and second trimester, as well as term placentae. SNAI1 was highly detected in the villous CTB nuclei, including some nucleoli, throughout the first and second trimester of pregnancy (Figure 2 ). In addition, it was highly expressed in the STB nuclei, as well as in the stromal mesenchyme. At term, SNAI1 was less detectable in both CTB and STB, relative to immunoreactivity in first and second trimester chorionic villi. During the first and second trimester, PARP1 (in red) and SNAI1 (in green) exhibited a high degree of coexpression within CTB nuclei (Figure 2, merged panels, yellow) . At term, co-expression was less apparent when compared to first and second trimester chorionic villi; however, SNAI1 was still expressed in both CTB and STB nuclei that did not coexpress PARP1.
BeWo trophoblast cells during syncytialization
Immunofluorescence analysis showed that when BeWo cells were cultured under proliferation conditions (0 h), PARP1 and SNAI1 were detected at low levels in the nuclei of the cells (Figures 3 and 4) . However, once BeWo cells were cultivated under syncytializationpromoting conditions, PARP1 and SNAI1 became highly localized to the cell nucleoplasm, including some nucleoli. These observations were concomitant with a decrease in CDH1 expression at cell-cell adhesions.
In correlation with increased PARP1 immunolocalization during BeWo syncytialization, immunoblot analysis of PARP1 expression in these cells demonstrated a significant increase in expression at , and term human placenta demonstrating PARP1 (red) co-localization with SNAI1 (green). Note the intense co-immunolocalization (arrows) of PARP1 and SNAI1 in nuclei of villous CTB during the first and second trimester. SNAI1 was more readily detectable in both stromal mesenchyme (Str) and the STB layer relative to PARP1. Rabbit (Rb) IgG and mouse (Ms) IgG labeled panels (W8) represent the use of nonspecific immunoglobulins in place of the primary antisera as negative controls for immunofluorescence analysis. Scale bar = 25 μm.
12 h (P < 0.05, n = 4) compared to all other timepoints sampled except 24 h (Supplemental Figure S1A ). There was a significant decrease in PARP1 expression at 36 h compared to 9, 12, 18, 24, and 48 h, but expression recovered at 48 h in correlation with marked immunolocalization of PARP1 in BeWo nucleoplasm. Overall, after 48 h of culture, PARP1 expression decreased significantly at 72 and 96 h of culture compared to all other timepoints except 36 and 60 h.
PARP1 and SNAI1 promoter activities during BeWo syncytialization
To determine if PARP1 and SNAI1 gene promoter activities were upregulated during BeWo syncytialization, luciferase reporter assays were performed. BeWo cells were transfected with either a PARP1 or a SNAI1 promoter fused to a luciferase reporter gene and subsequently cultured under proliferation-or syncytialization- (12, 24 , and 48 h) followed by fixation in 4% paraformaldehyde/PBS. Cells were then co-immunostained for CDH1 and PARP1. The representative images demonstrate that the extent of localization of PARP1 to the cell nuclei correlates with the downregulation of CDH1 expression at cell-cell membranes. Rabbit (Rb) and mouse (Ms) IgG panels without DAPI (12 h timepoint), nonspecific immunoglobulins of the appropriate animal species were used as specificity controls in place of the primary antisera. Nuclei in CDH1 immunofluorescence panels were detected with DAPI. Data are representative of three independent experiments. Scale bar = 50 μm.
promoting conditions. A luciferase reporter construct under the control of the GCM1 promoter was also used in these experiments due to its known upregulation during trophoblast fusion [17, 18] . A luciferase reporter construct under the control of the GAPDH promoter and a promoterless construct were used as negative controls. PARP1 promoter activity was significantly increased during syncytialization relative to proliferation conditions ( Figure 5A , P < 0.05), indicating PARP1 gene expression was increased during syncytialization. Similarily, SNAI1 promoter activity also markedly increased during syncytialization compared to proliferation conditions ( Figure 5B , P < 0.05). As expected, GCM1 promoter activity was significantly elevated in BeWo cells cultured under syncytialization conditions relative to proliferation conditions ( Figure 5C , P < 0.05). (12, 24 , and 48 h) followed by fixation in 4% paraformaldehyde/PBS. Cells were then co-immunostained for CDH1 and SNAI1. The representative images demonstrate that the extent of localization of SNAI1 to the cell nuclei correlates with the downregulation of CDH1 expression at cell-cell membranes. Rabbit (Rb) and mouse (Ms) IgG panels without DAPI (12 h timepoint), nonspecific immunoglobulins of the appropriate animal species were used as specificity controls in place of the primary antisera. Nuclei in CDH1 immunofluorescence panels were detected with DAPI. Data are representative of three independent experiments. Scale bar = 50 μm.
In contrast, a reporter construct under the control of the GAPDH promoter did not show any significant difference in relative luciferase activity between proliferation-or syncytialization-promoting conditions ( Figure 5D ). A promoterless reporter construct demonstrated very low background levels in both conditions as expected ( Figure 5E ).
PARP1 and SNAI1 promoter activities upon ILK overexpression and syncytialization
To determine if PARP1 and SNAI1 promoter activities could be induced by ILK expression during syncytialization, the same luciferase reporter constructs were co-transfected into BeWo cells with pEGFP-C3 expression plasmids containing dn-, wt-or ca-ILK cDNAs and the cells were then cultured under syncytializationpromoting conditions. Preliminary experiments verified the viability of these vectors as transient expression of the resulting EGFP-fusion proteins for 48 h in BeWo cells under syncytialization conditions resulted in detection of these proteins on immunoblots at the expected molecular weight of 80 kDa, in addition to endogenous levels of ILK (Supplemental Figure S1B) . These results also confirmed that the expression levels of the various EGFP-ILK proteins were comparable between the respective transfectants.
PARP1 and SNAI1 promoter activities were significantly altered when co-transfected with the ILK-containing vectors in contrast to GCM1 or GAPDH promoter activities ( Figure 6A-E) . Specifically, both PARP1 and SNAI1 promoter activities were significantly reduced with transient dn-ILK overexpression compared to the empty vector control (Figure 6A and B; P < 0.05), while they were significantly increased upon transient overexpression of wt-ILK compared to dn-ILK or vector control (Figure 6A and B; P < 0.05). Similarly, PARP1 and SNAI1 promoter activities were significantly increased upon transient overexpression of ca-ILK compared to all other groups (Figure 6A and B; P < 0.05).
PARP1 and SNAI1 expression and incidence of syncytialization upon ILK silencing
The necessity of ILK for BeWo syncytialization was then addressed by depleting ILK mRNA using ILK-specific siRNA. Immunoblot analyses of BeWo cells transfected with ILK siRNA or the NTC siRNA were conducted ( Figure 7A ). Subsequent densitometric analysis demonstrated that ILK expression was significantly downregulated in the cells transfected with ILK siRNA when compared with the cells transfected with the NTC siRNA ( Figure 7B ; P < 0.05). Importantly, when ILK expression was significantly depleted, PARP1 expression remained unchanged ( Figure 7C ), SNAI1 expression significantly decreased ( Figure 7D ; P < 0.05), and CDH1 expression significantly increased ( Figure 7E ; P < 0.05). The incidence of fusion in ILK-depleted BeWo cells compared to NTC was also examined in cells grown under syncytialization-promoting conditions for 48 h. Immunofluorescence analysis of CDH1 expression to assess syncytialization illustrated that cells transfected with ILK siRNA showed significantly less syncytialization compared to cells transfected with the NTC siRNA ( Figure 7F ; P < 0.05).
Discussion
We previously reported that ILK was highly detectable in situ in human villous mononuclear CTB and transient overexpression of ILK in BeWo trophoblast cells significantly increased cell syncytialization [29, 30] . ILK, PARP1, and SNAI1 can participate in a pathway to downregulate CDH1 expression for EMT [32, 33] ; however, PARP1 and SNAI1 have not been thoroughly examined in the process of trophoblast syncytialization. Thus, we investigated the expression of these proteins in human chorionic villi and BeWo trophoblast cells to determine the potential for an ILK-PARP1-SNAI1 mechanism underlying trophoblast syncytialization. 
PARP1 and SNAI1 involved in syncytialization
PARP1 is an abundant nuclear enzyme that regulates nuclear processes such as DNA repair, chromatin remodeling, and regulation of gene expression under basal, signal-activated, and stress-activated conditions [42] . SNAI1 is a transcriptional repressor of CDH1 and master controller of the process of EMT [43] . Notably, PARP1 can regulate SNAI1 protein stability [44] . However, a clear understanding of the spatiotemporal expression of PARP1 and SNAI1 in the human placenta has been lacking in the field. Two laboratories have examined SNAI1 expression in human chorionic villi from patients with pre-eclampsia or normal term pregnancies using immunohistochemistry. Blechschmidt et al. [45] reported weak SNAI1 immunoreactivity in villous CTB in all samples, while Fedorova et al. [46] showed high levels of SNAI1 immunostaining in CTB nuclei of normal term placentae and a reduction of immunoreactivity in pre-eclamptic placentae. Our comprehensive analyses extend these results and show that PARP1 and SNAI1 were both highly detectable in CTB and were co-expressed in the nuclei of the monolayer. PARP1 was expressed to a lesser extent in STB nuclei, while SNAI1 remained highly detectable within them. The SNAI1 expression in STB nuclei could be indicative of recent syncytialization events with the protein subsequently awaiting degradation or it may have STB-specific functions that have yet to be identified. For example, a proportion of STB demonstrate transcriptional activity [47] and perhaps SNAI1 has a regulatory role in these cells. Fedorova et al. [46] did not report SNAI1 immunoreactivity in the STB, but our results may reflect the use of different antisera and the very high resolving power of laser scanning confocal microscopy. Complementing our examination of chorionic villi, immunolocalization of PARP1, and SNAI1 expression in BeWo cells revealed that both proteins markedly increased within the nucleoplasm during 48 h of syncytialization. The latter result correlates with our previous report of increased SNAI1 protein expression in BeWo cells at 24, 36, and 48 h of culture in syncytialization conditions [30] . Similarly, supplementary data showing a significant increase in PARP1 protein expression at 12 h followed by maintenance of PARP1 expression at 24 and 48 h correlates with the high levels of PARP1 immunolocalization within the nucleoplasm during BeWo syncytialization. Of note, PARP1 expression during BeWo syncytialization significantly decreased at 72 and 96 h of culture. This correlates with the reduced immunolocalization of PARP1 we observed in STB of human chorionic villi in situ. PARP1 and SNAI1 promoter activities were also significantly upregulated during BeWo cell syncytialization compared to proliferation conditions. This indicates that transcription of both genes is likely induced during syncytialization and could contribute to the subsequent translation and observed changes in spatial detection of the proteins. Confirmation of the validity of the luciferase reporter assays was demonstrated with increased GCM1 promoter activity during syncytialization as this transcription factor regulates SYNA expression and plays a role in trophoblast syncytialization during placental development [17, 18, 48] . Notably, when wt-ILK and ca-ILK proteins were transiently overexpressed in BeWo cells during syncytialization, both PARP1 and SNAI1 promoter activities were significantly increased indicating that ILK can modulate the expression of both genes. In contrast, GCM1 promoter activity was unaffected by wt or mutant ILK protein overexpression and thus not likely involved in an ILK-mediated syncytialization pathway.
ILK is necessary for BeWo trophoblast syncytialization
Small interfering RNA-mediated ILK depletion in BeWo cells during syncytialization resulted in significantly decreased SNAI1 protein expression and significantly increased CDH1 expression, while PARP1 expression was largely unaffected. McPhee et al. [33] reported similar results following siRNA-mediated ILK depletion in PC3 cells. The lack of changes in PARP1 expression in our ILK silencing experiments may be a result of its high level of ubiquitous expression in cells and multiple roles in processes such as transcription, DNA repair, chromatin remodeling, translation, and telomere maintenance [42, 49] . Only a small fraction of PARP1 may be working within an ILK signaling pathway to help regulate syncytialization. Notably, BeWo syncytialization was dramatically reduced upon ILK depletion indicating the necessity of ILK for the process. These results correlate with the work of Miller et al. [50] who demonstrated that overexpression of ILK in L6 myoblasts resulted in increased ILK activity and stimulation of myoblast fusion into myotubes. Furthermore, overexpression of ILK was also previously demonstrated to aid syncytialization and hormonal differentiation of BeWo cells [30] . BeWo cells are a choriocarcinoma-derived cell line model for study of trophoblast differentiation, but do possess some limitations [51] . For example, different cell line strains possess variable fusion rates and the stage of villous trophoblast gestation the BeWo cells actually represent is unknown. They are also nonprimary cells making complete extrapolation of experimental results to in vivo villous trophoblast challenging. Nevertheless, the BeWo model is extensively used for the study of villous trophoblast biology because the shift from proliferation to syncytialization can be fine-tuned, with the addition of reagents such as forskolin, and it retains most characteristics of villous trophoblast including hormone production [19, [35] [36] [37] [38] 51] .
The link between ILK, PARP1, SNAI1, and CDH1 within a signaling pathway has been established over the last 10-15 years in understanding the process of EMT. Somasiri et al. [52] reported that overexpression of ILK in the Scp2 mouse mammary epithelial cell line induced loss of CDH1 expression and EMT. Overexpression of ILK in the human colon carcinoma-derived cell lines SW480 and DLD-1 also stimulated SNAI1 expression [32] . Alternatively, when ILK activity was inhibited with KP-SD-1, CDH1 promoter activity and protein expression increased while SNAI1 promoter activity was inhibited in a dose-dependent manner. ILK was subsequently shown to regulate SNAI1 transcription by binding to a 65-base-pair region in the SNAI1 promoter termed the Snail-ILK-Responsive Element (SIRE) [33] . Using a SIRE assay coupled with mass spectrometry, PARP1 was then identified by the authors to bind to the SIRE in an ILK-dependent manner leading to CDH1 downregulation. Thus, a model was proposed where ILK induces PARP1 binding to the SNAI1 SIRE to modulate SNAI1 expression and control CDH1 expression for subsequent EMT processes. Further confirmatory reports of ILK and PARP1 and/or SNAI1 participating in EMT have since been published [53] [54] [55] . Our data now indicate the involvement of these proteins in syncytialization.
It has been reported that the SRC family kinases have multiple roles in trophoblast differentiation [15] . ILK can complex with SRC and induce signaling cascades with MAPK1/3 [27, 56] , which are important for initiation of trophoblast differentiation and for regulating PARP1 activation [14, 57] . Thus, it is possible that a broader signaling network involving all of these proteins can regulate transcriptional regulators such as SNAI1 or even TWIST to control trophoblast syncytialization.
Overall, all of our data provide substantial evidence that ILK can indirectly or directly downregulate CDH1 expression and regulate syncytialization. The mechanism likely involves at least an ILK-PARP1-SNAI1 signaling pathway in trophoblast and future work will more specifically examine the molecular aspects and necessity of PARP1 and SNAI1 signaling in trophoblast.
Supplementary data
Supplementary data are available at BIOLRE online.
Supplemental Figure S1 . (A) Expression of PARP1 during BeWo syncytialization. Cells were cultured under proliferation and syncytialization-promoting conditions and lysed for immunoblot analysis as described in the Materials and Methods. Representative immunoblots from four independent experiments are shown demonstrating PARP1, GAPDH, and GCM1 protein expression during BeWo syncytialization over 96 h. PARP1 expression was significantly increased at 12 h ( * ; ANOVA, Newman-Keuls; P < 0.05) compared to all other timepoints examined except 24 h. There was a significant decrease in PARP1 expression at 36 h compared to 9, 12, 18, 24, and 48 h ( * * , P < 0.05), but expression recovered at 48 h. After 48 h of culture, PARP1 expression decreased significantly at 72 and 96 h of culture compared to all other timepoints except 36 and 60 h ( * * * , P < 0.05). Upregulation of glial cell missing 1 (GCM1) protein expression confirmed induction of syncytialization. GCM1 was detected with a rabbit polyclonal antiserum (Cat # P100836-050; concentration used: 0.5 μg/mL; Aviva Systems Biology, San Diego, CA). (B) Assessment of ILK-EGFP fusion protein expression in BeWo cells after 48 h of culture under syncytialization conditions. Cells were transfected with empty pEGFP C3 vector (pEGFP C3), pEGFP C3 containing wild-type ILK (pEGFP C3-wtILK), dominant negative E359K ILK (pEGFP C3-dnILK), or constitutively active S343D ILK (pEGFP C3-caILK) and prepared for immunoblot analysis as described in the Materials and Methods. EGFP-ILK proteins were detectable at the expected molecular weight of 80 kDa, in addition to endogenous levels of ILK, and expression levels of EGFP-ILK proteins were comparable between the respective transfectants. Control represents nontransfected BeWo cells.
